Clinical trial shows experimental drug's ability to knock down pancreatic cancer's defense

Clinical trial shows experimental drug's ability to knock down pancreatic cancer's defense

http://ift.tt/2rpEBFS

By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment, according to a Phase 2 clinical trial led by an investigator at Fred Hutchinson Cancer Research Center.



Singularity

via http://ift.tt/orfraw

May 31, 2017 at 07:25AM

Comments

Post a Comment

Popular posts from this blog

How to capture videos of brains in real time

Image
How to capture videos of brains in real time http://ift.tt/2sTaUgJ Individual neurons firing within a volume of brain tissue (credit: The Rockefeller University) A team of scientists has peered into a mouse brain with light, capturing live neural activity of hundreds of individual neurons in a 3D section of tissue at video speed (30 Hz) in a single recording for the first time. Besides serving as a powerful research tool, this discovery means it may now be possible to “alter stimuli in real time based on what we see going on in the animal’s brain,” said Rockefeller University’s Alipasha Vaziri , senior author of an open-access paper published June 26, 2017 in Nature Methods . By dramatically reducing the time and computational resources required to generate such an image, the algorithm opens the door to more sophisticated experiments, says Vaziri, head of the Rockefeller Laboratory of Neurotechnology and Biophysics . “Our goal is to better understand brain function by monitor...
Read more

Inequalities in malaria research funding in sub-Saharan Africa

Image
Inequalities in malaria research funding in sub-Saharan Africa http://ift.tt/2tZzF9s A quarter of countries in sub-Saharan Africa receive very little funding for research into malaria despite having high malaria-related death rates. In a new study, led by the University of Southampton and published in The Lancet Global Health , countries have been ranked according to how much research and non-research funding they receive from major public and philanthropic global health funders to combat the disease. The study examined the portfolios of several of the major global health research funders and compared funding levels to national malaria-related burden of disease. They could not find any investment for malaria research in countries such as Sierra Leone, Mauritania, Chad, Congo and Central African Republic. Chad, Congo and Central African Republic are among the countries with the highest malaria death rates in the world at 71.9, 64.84 and 128.34 per 100,000 of the population resp...
Read more